long-term disease-free survival in myeloma
Published 3 years ago • 1.9K plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
3:31
relevance of the ipss-r during sct in patients with mds in the molecular classification era
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
2:25
real-world study of tixagevimab/cilgavimab in pre-exposure prophylaxis for allosct recipients
-
2:22
bispectral index™ byte 11: bis™ monitoring in elderly patients
-
2:59
advances in haematology over the past 60 years
-
3:19
the rest study: isatuximab-bortezomib-lenalidomide in elderly patients with myeloma
-
1:09
what have been the major developments in your subspecialty?
-
14:15
progress report iv - tímea mátyási-dombi
-
5:19
a 17-year fight against multiple myeloma
-
1:31
multiple myeloma patient story - carmen
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
5:54
day in the life - haematology - dr ellen maxwell
-
1:56
training and supporting the next generation of scientists | versiti blood research institute
-
25:39
blood transfusion, the true cost behind it
-
13:04
progress report iv - jázmin németh
-
3:00
why blood-based biomarkers allow for effective use of innovative dmts in the future?
-
0:59
versiti | journey of research and discovery at the blood research institute
-
0:59
versiti | 70 year legacy of discovery and innovation
-
45:26
ret21-section xviii artificial intelligence and big data